ID

41569

Descripción

Study ID: 111114 Clinical Study ID: 111114 Study Title: A Randomized, Double-Blind, Parallel-Group, 24-Week Study to Evaluate the Efficacy and Safety of ADVAIR™ DISKUS™ (Fluticasone Propionate/Salmeterol Combination Product 250/50mcg Inhalation Powder) BID Plus Spiriva HandiHaler (Tiotropium Bromide Inhalation Powder 18mcg) QD Versus Spiriva QD Plus Placebo DISKUS BID in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00784550 https://clinicaltrials.gov/ct2/show/NCT00784550 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: N/A Trade Name: Tiotropium Bromide, Fluticasone Propionate/Salmeterol Study Indication: Pulmonary Disease, Chronic Obstructive The purpose of the study is to determine the efficacy and safety of the combination of ADVAIR DISKUS® 250/50mcg (FLUTICASONE PROPIONATE/SALMETEROL COMBINATION PRODUCT) plus SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) compared to SPIRIVA® HANDIHALER® inhaler 18mcg (TIOTROPIUM) in patients with COPD. There are a total of 6 visits: Screening (Visit 1), Randomization (Visit 2), and after 4 (Visit 3), 8 (Visit 4), 16 (Visit 5) and 24 (Visit 6) weeks of treatment. This form (Randomisation, Run-in Failure) is to be filled out at Visit 2 (Randomisation).

Link

https://clinicaltrials.gov/ct2/show/NCT00784550

Palabras clave

  1. 11/11/2020 11/11/2020 -
Titular de derechos de autor

GlaxoSmithKline

Subido en

11 de novembro de 2020

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Efficacy and Safety of ADVAIR DISKUS Plus Spiriva HandiHaler Versus Spiriva HandiHaler in COPD NCT00784550

Randomisation, Run-in Failure

Administrative Data
Descripción

Administrative Data

Alias
UMLS CUI-1
C1320722
Subject identification number
Descripción

Subject identification number

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
Date of visit/assessment
Descripción

Date of visit/assessment

Tipo de datos

date

Alias
UMLS CUI [1]
C1320303
UMLS CUI [2]
C2985720
Randomisation number
Descripción

Randomisation number

Alias
UMLS CUI-1
C0034656
UMLS CUI-2
C0237753
Was the subject able to be randomised?
Descripción

Randomisation possible

Tipo de datos

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0332149
Randomisation number
Descripción

Randomisation number

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Run-in Failure
Descripción

Run-in Failure

Alias
UMLS CUI-1
C1710476
Was this subject a run-in failure?
Descripción

Run-in Failure

Tipo de datos

text

Alias
UMLS CUI [1]
C1710476
Run-in failure date
Descripción

Date is optional and should be removed from the prompt when date is not being captured.

Tipo de datos

date

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0011008
Select primary reason
Descripción

Primary reason for run-in failure

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0566251
If primary reason for run-in failure: Adverse Event, exacerbation of medical condition under investigation?
Descripción

Primary reason for run-in failure: Adverse Event, COPD exacerbation under investigation

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0877248
UMLS CUI [1,3]
C0566251
UMLS CUI [2,1]
C1261322
UMLS CUI [2,2]
C0740304
If primary reason for run-in failure: Investigator discretion, specify
Descripción

Primary reason for run-in failure: Investigator discretion

Tipo de datos

text

Alias
UMLS CUI [1,1]
C1710476
UMLS CUI [1,2]
C0566251
UMLS CUI [1,3]
C0008961
UMLS CUI [1,4]
C0022423

Similar models

Randomisation, Run-in Failure

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Subject identification number
Item
Subject identification number
text
C2348585 (UMLS CUI [1])
Date of visit/assessment
Item
Date of visit/assessment
date
C1320303 (UMLS CUI [1])
C2985720 (UMLS CUI [2])
Item Group
Randomisation number
C0034656 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Item
Was the subject able to be randomised?
text
C0034656 (UMLS CUI [1,1])
C0332149 (UMLS CUI [1,2])
Code List
Was the subject able to be randomised?
CL Item
No (N)
CL Item
Yes, provide randomisation number (Y)
Randomisation number
Item
Randomisation number
integer
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item Group
Run-in Failure
C1710476 (UMLS CUI-1)
Item
Was this subject a run-in failure?
text
C1710476 (UMLS CUI [1])
Code List
Was this subject a run-in failure?
CL Item
No (N)
CL Item
Yes, complete run-in failure date and reason (Y)
Run-in failure date
Item
Run-in failure date
date
C1710476 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
Select primary reason
integer
C1710476 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
Code List
Select primary reason
CL Item
Adverse Event, check if exacerbation of medical condition is under investigation (1)
CL Item
Lack of efficacy (2)
CL Item
Protocol deviation (3)
CL Item
Lost to follow-up (6)
CL Item
Investigator discretion, specify (7)
CL Item
Withdrew consent (8)
Primary reason for run-in failure: Adverse Event, COPD exacerbation under investigation
Item
If primary reason for run-in failure: Adverse Event, exacerbation of medical condition under investigation?
boolean
C1710476 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
C0566251 (UMLS CUI [1,3])
C1261322 (UMLS CUI [2,1])
C0740304 (UMLS CUI [2,2])
Primary reason for run-in failure: Investigator discretion
Item
If primary reason for run-in failure: Investigator discretion, specify
text
C1710476 (UMLS CUI [1,1])
C0566251 (UMLS CUI [1,2])
C0008961 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial